Navigation Links
Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy

- Results Presented at Society of Nuclear Medicine Annual Meeting -

WASHINGTON, June 05, 2007 /PRNewswire-FirstCall/ -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that initial results from a Phase I study with the Company's humanized anti-MUC1 monoclonal antibody (hPAM4), labeled with the radioisotope, Yttrium-90 (Y-90), in patients with unresectable and metastatic pancreatic cancer reported at the 54th Annual Meeting of the Society of Nuclear Medicine in Washington, DC, by Seza Gulec, MD, Center for Cancer Care, Goshen, IN, were encouraging.

Stage III pancreatic cancer patients who have failed one line of chemotherapy and Stage IV patients with or without a history of systemic therapy were eligible for the open-label, multicenter dose-escalation study. Prior to therapy, all patients received a diagnostic dose of hPAM4 labeled with the radioisotope, Indium-111, to ensure an acceptable distribution within the body and radiation dose to the pancreas for intended therapy. Patients then received a single infusion of 90Y-hPAM4 with the Y-90 dose escalating in increments of 5mCi/m(2) in groups of 3-6 patients. CT based measurements were used to evaluate tumor response 4, 8, and 12-weeks after therapy.

Results from the Goshen study site were reported at the meeting. Eleven patients, of whom 9 had previously received systemic therapy predominantly with gemcitabine regimens, and 2 patients who were chemotherapy naïve were enrolled at this cancer center. In all patients, pre-therapy imaging with 111In-hPAM4 showed acceptable distribution within the body and radiation dosage to the pancreas. 90Y-hPAM4 was administrated at 15 mCi/m(2), 20 mCi/m(2) or 25 mCi/m(2). One patient, enrolled into the clinical trial at this site, showed shrinkage of a liver lesion.

Two patients, from other
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... 2014  4WEB Medical announces the formal launch of ... osteotomy implants on the market today at this ... in Chicago .  The Osteotomy Truss ... needs with 74 size options included in one versatile ... only 15 to 18 implant sizes, which limited a ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
... Cellceutix Corporation (Pink Sheets: CTIX ) today ... Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with ... Cellceutix CEO, Leo Ehrlich, commented, "It,s relatively uncommon ... a compound before clinical trials are underway.  The process ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Barclay,s 2011 Global Healthcare Conference ... presentation will be webcast live and can be accessed ...
Cached Medicine Technology:Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 2Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 3
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... 2014 Recently, Best Cheap Hosting ... launched its new website. The new site provides ... hosting products for customers. Here, people can find ... purchasing decision. Also, it has recommended some excellent ... One of the great web hosting suppliers, InMotion ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking coffee ... is re-visiting that advice and changing his stance after considering ... have on oral health. “There’s good news and great news,” ... beneficial in protecting against gum disease, and red wine can ... was from the September 2014 issue of Boston University ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Recently, UWDress.com, ... dresses and women’s special occasion outfits, has launched a ... The company’s prom outfits are popular among worldwide clients. ... get wholesale prom dresses on its website. ... for customers from around the world. Great custom made ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... million of their customers may have had their credit card ... late last year, spawning a slew of headline articles ... but those weren’t the only eye opening numbers. , ... numbers were stolen, almost like it’s a way to score ...
Breaking Medicine News(10 mins):Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5
... Healthcare Leaders With Information and,Best Practices Related ... WASHINGTON, April 17 The new ... that will eliminate or,reduce payments for three ... a two-day conference for healthcare executives and ...
... Projects show potential of computer science to profoundly impact prediction ... and treatment ... with the ability to predict and prevent adverse drug responses,within ... illnesses such as Parkinson,s disease and Alzheimer,s,disease, are just two ...
... In a move that will benefit children of ... premier childrens hospitals in the United States, and the ... have formalized a longtime relationship by officially becoming international ... sister cities, the formal linkage of hospitals in two ...
... Trust Inc.,(NYSE: CRE ) today announced it named ... Care,s Board of Directors, which increases the,number of members ... as President of Corporate Finance at CIT, Owens, 48, ... leaders,in assessing their go-to-market models, developing integrated distribution,platforms that ...
... 2008 Babies with an eye-alignment disorder called ... but development catches up after corrective surgery, reports ... (American Association for Pediatric Ophthalmology and Strabismus). , ... Retina Foundation of Southwest Texas, Dallas, the researchers ...
... Technology through ... ... Medical,Solutions USA Inc. (http://www.siemens.com/healthcare ) today announced a ... in numerous,strategic healthcare industry organizations., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
Cached Medicine News:Health News:APIC Conference to Address New CMS Regulations 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 3Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 4Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 5Health News:Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals 2Health News:Care Investment Trust Names Walter J. Owens to Board of Directors 2Health News:Infantile esotropia linked to developmental delays 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 3Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 4Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 5
ELISA kit for Varicella-zoster IgM....
... (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is ... of IgG antibody to VZV in human ... used for the determination of immune status. ... used to demonstrate seroconversion or a significant ...
... The Zeus Scientific, Inc. Mumps IgG ELISA ... detection of Mumps IgG antibody in human ... the results of this test, together with ... determination of immune status, and/or aid in ...
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
Medicine Products: